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Edited by Varda RotterAbstract Serine/threonine phosphatases such as PP1, PP2A,
and PP2B are well known to regulate the transition phase of
the cell cycle. However, the function of PP2Cc in cell cycle pro-
gression is still unclear. In the present study, we report the char-
acterization of PP2Cc in mammalian cells during the cell cycle.
After release of synchronized cells from thymidine block, over-
expression of PP2Cc led to accumulation in the S phase. The
amount of endogenous p21WAF1/CIP1 protein was markedly re-
duced by the expression of PP2Cc. The degradation of
p21WAF1/CIP1 induced by PP2Cc was mediated in a protea-
some-dependent manner. In addition, the phosphatase activity
of PP2Cc was capable of repressing the level of p21WAF1/CIP1
protein. Phosphorylation of Rb was also reduced in cells
expressing PP2Cc. Taken together, these results indicate that
PP2Cc-induced S phase accumulation may be associated with
proteasome-directed p21WAF1/CIP1 degradation.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Proteasome1. Introduction
In eukaryotic cells, serine/threonine protein phosphatases
regulate aspects of cell metabolism such as proliferation, diﬀer-
entiation, and cell death. During cell division, serine/threonine
phosphatases such as PP1, PP2A, and PP2B are well known to
regulate the transition phase of the cell cycle [1,2]. PP2C is acti-
vated in the presence of metal ions such as Mg2+ and Mn2+,
but is resistant to okadaic acid [3,4]. The PP2C family includes
mammalian PP2Ca, PP2Cb, PP2Cc, PP2Cd, and the recently
identiﬁed PP2Ce [5,6]. These enzymes play a role in various
cellular activities including cell cycle regulation. For example,
Ptc2 and Ptc3, which are homologues of human PP2C, regu-
late Cdc28 activation [7], and Xenopus PP2C dephosphorylates
Cdc2 kinase [8]. Studies of PP2C family members such as
PP2Ca and PP2Cb have shown them to be involved in cellAbbreviations: PBS, phosphate-buﬀered saline; PP2Cc, protein phos
phatase 2Cc; BrdU, bromodeoxyuridine
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eties. Pucycle regulation [9–11]. PP2Cc is known to dephosphorylate
speciﬁc substrates known as splicing factors that are required
for formation of the spliceosome [12]. The role of human
PP2Cc during the cell cycle remains unclear, though mouse
PP2Cc, FIN13, induces growth inhibition via G1 and early S
phase arrest [13]. p21WAF1/CIP1 is a cell cycle regulatory protein
that inhibits both cyclin-dependent kinases and the replication
protein PCNA through direct protein interactions [14].
p21WAF1/CIP1 is an unstable protein and post-translational
regulatory mechanisms play important roles in determining
its steady-state levels.
We report here that S phase arrest in the cell cycle caused by
upregulation of PP2Cc was associated with the degradation of
p21WAF1/CIP1 via a proteasome-dependent pathway in 293
cells.2. Materials and methods
2.1. Plasmids and transfection
To construct expression plasmids, clones encoding PP2Cc (kindly
provided by Dr. Travis) or PP2Cc D496A (kindly provided by Dr.
Krainer) were ampliﬁed by PCR using the following primers; forward:
5 0-ggtatgggtgcctacct-3 0 and reverse: 5 0-ggtaccgtctcgcttggc-3 0. The PCR
products were digested by Kpn1–BamH1 restriction enzymes and sub-
cloned with the expression vector pEGFP-C1 (Clontech) or
pCDNA3.1 (Invitrogen) using T4 ligase (TaKaRa). The DNA
sequences of all constructs were checked. A human wild-type p53
expression vector (pCMV-neo-BAM) was kindly provided by
Dr. B. Vogelstein. To establish cell lines expressing PP2Cc, 293 cells
were initially transfected with GFP-PP2Cc or GFP empty vector
using ExGen500 reagent (Fermentas) following the manufacturer’s
instructions.2.2. Cell culture and synchronization
Human kidney 293 cells were cultured in MEM-a supplemented
with 10% fetal bovine serum and antibiotics, and maintained in a
humidiﬁed incubator at 37 C with 5% CO2. The 293 cells were syn-
chronized by the double thymidine block method or serum starvation
method. In brief, to arrest cells in the G1/S phase, they were treated
with 2 mM thymidine for 16 h, released into normal medium for 9 h,
and then incubated for 16 h in medium containing 2 mM thymidine.
For synchronization of the G0/G1 phase, cells were incubated for
24 h in serum-deprived medium and then released into normal medium
to progress through the cell cycle.2.3. Fluorescence-activated cell sorting (FACS) analysis
Synchronized cells expressing GFP fusion protein were harvested
and ﬁxed in 70% ethanol at 4 C for 30 min. Before analysis, the cells
were washed once in phosphate-buﬀered saline (PBS) and stained with
PBS containing 25 lg/mL propidium iodide and 200 lg/mL RNase
A at 4 C for 1 h. GFP-expressing cells were recovered by FACS.blished by Elsevier B.V. All rights reserved.
E.-J. Suh et al. / FEBS Letters 580 (2006) 6100–6104 6101Analyses were performed with a FACScan ﬂow cytometer (Becton
Dickinson). Cell cycle distributions were calculated using the program
CytoFlow version 2.2.
2.4. BrdU incorporation assay
The proportion of cells in the S phase of the cell cycle was deter-
mined through immunoﬂuorescence for incorporated bromodeoxyuri-
dine (BrdU). Cells were plated on coverslips and incubated with 10 lM
BrdU (Sigma) for 2 h. After labeling, the coverslips were rinsed in PBS
and the cells were ﬁxed with 4% paraformaldehyde for 15 min. The
ﬁxed cells on coverslips were washed twice in PBS and then permeabi-
lized in 2 N HCl at 4 C for 10 min. After neutralization with 0.1 M
tetraborate, the cells were washed in PBS with 0.5% Triton X-100
and incubated with mouse anti-BrdU antibody (Sigma). Nuclei were
counter-stained with DAPI. The processed cells were washed in PBS
with 0.5% Triton X-100, mounted on slides, and examined under an
LSM510 (Carl Zeiss) for quantiﬁcation of cell proliferation. At least
four ﬁelds were counted for each plate and all experiments were per-
formed in triplicate.
2.5. Reverse-transcription PCR (RT-PCR)
Total RNA was isolated from the 293 cells using Trizol reagent
(Invitrogen) and transcribed using MMLV reverse transcriptase
(TaKaRa) with oligo(dT) primer. The aliquots of cDNA were usedFig. 1. PP2Cc induces S-phase arrest in 293 cells. (A) Cells expressing G
thymidine block and analyzed by ﬂow cytometry. The gated population repr
and G2/M phases are indicated below each gate. Experiments were repeated
assayed for BrdU incorporation by immunoﬂuorescence staining and meas
nuclear localization and for total cell counts. Graphs represent the means ±for PCR ampliﬁcation. The primers used to amplify p21WAF1/CIP1 were
5 0-tggggatgtccgtcagaaccc-30 (forward) and 5 0-ttagggcttcctcttggagaa-30
(reverse). For GAPDH as a control, the primers were 5 0-catcaccatcttc-
caggagc-3 0 (forward) and 5 0-ccacctggtgctcagtgtag-30 (reverse). The
PCRs consisted of an initial cycle at 94 C for 30 s followed by 30
cycles at 94 C for 1 min, 53 C for 1 min, and 72 C for 1 min, and
a ﬁnal extension for 1 min at 72 C. The ampliﬁed PCR products were
analyzed by 0.8% agarose gel electrophoresis and ethidium bromide
staining.2.6. Western blotting
Cells were washed with cold PBS and lysed in ice-cold lysis buﬀer
(50 mM Tris–HCl, 150 mM NaCl, 1% NP-40, 0.1% SDS, protease
inhibitor cocktail (Roche), 50 mM NaF, and 0.2 M Na3VO4). Protein
extracts were electrophoresed by 12.5% SDS–PAGE and transferred
to a nitrocellulose membrane. The membrane was blocked in 5%
non-fat milk and incubated with diﬀerent antibodies at room temper-
ature. The protein signals were visualized by an enhanced chemilumi-
nescence reaction system (ECL; Santa Cruz, USA). Antibodies
against p21WAF1/CIP1, cyclin E (Upstate), or antin (Sigma) were used
at a concentration of 0.5 lg/mL. Antibodies against PP2Cc (Calbio-
chem), p53 (Santa Cruz), and Rb or p-Rb (Cell Signaling) were used
at a concentration of 1 lg/mL. Actin was used as an equal loading
control.FP (vector) or GFP-PP2Cc (PP2Cc) were synchronized with double
esents cells expressing GFP. The proportions of cells in the G0/G1, S,
three times with similar results. (B) Asynchronously growing cells were
ured by ﬂuorescence microscopy. DAPI staining was used to deﬁne
S.D. of three independent experiments.
Fig. 3. Proteasome inhibitor restores p21WAF1/CIP1 protein levels in
PP2Cc-expressing cells. After release from serum starvation, 293 cells
were treated with 20 lMMG132 for 8 h. Protein lysates were analyzed
by Western blotting with PP2Cc antibody.
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3.1. Cell cycle proﬁle of PP2Cc-induced cells
It is known that the mouse homologue of PP2Cc, FIN13,
plays a role in cell cycle progression [13]. However, the func-
tion of human PP2Cc in the cell cycle remains unclear. To
study the cell cycle progression of upregulated PP2Cc in
human cells, a vector expressing PP2Cc was transfected in
293 cells, which have low levels of endogenous PP2Cc (unpub-
lished data). Cells were harvested at various time points after
release from double thymidine blocking, and the cell cycle pro-
ﬁle was determined by FACS analysis. Representative proﬁles
are shown in Fig. 1A. Over-expression of PP2Cc induced accu-
mulation in the S phase compared with controls. Cells contain-
ing the vector only were used as a control. In all cells tested,
expression of PP2Cc reduced the population of cells in the
G1 and G2/M stage. In particular, a decrease in the percentage
of cells in the G2/M phase accompanied the PP2Cc-induced
accumulation of cells in the S phase. S phase accumulation
with PP2Cc was conﬁrmed by incorporation of BrdU using
immunoﬂuorescence staining. Over-expression of PP2Cc in-
creased the proportion of cells in the S phase by 53% (Fig. 1B).
These results suggest that PP2Ccmay play a role in prolong-
ing the S phase during the cell cycle.
3.2. Expression of p21 in cells expressing PP2Cc
To identify the proteins involved in PP2Cc-induced S-phase
arrest, we tested the eﬀect of PP2Cc on the expression of the
cyclin-dependent kinase inhibitor p21WAF1/CIP1, which can
lead to cell cycle arrest by inhibiting DNA replication [15].
We transfected 293 cells with PP2Cc constructs (the transfec-
tion eﬃciency was about 70%). As shown in Fig. 2A, the
amount of endogenous p21WAF1/CIP1 protein was markedly re-
duced by expression of PP2Cc. To determine whetherFig. 2. PP2Cc downregulates p21WAF1/CIP1. (A) 293 cells were
transfected with empty GFP vector (vector) or GFP-PP2Cc plasmid.
Cells were assayed by Western blotting for p21WAF1/CIP1 and actin. (B)
Cells were transfected with pEGFP-PP2Cc and PP2Cc mutant. At
24 h post-transfection, cells were harvested and total RNA was
isolated for RT-PCR assay. (C) 293 cells expressing PP2Cc or PP2Cc
D496A (phosphatase dead mutant) were serum-deprived for 24 h and
stimulated by 10% serum addition. Cells were harvested at the
indicated time points and processed for Western blotting.p21WAF1/CIP1 protein levels were paralleled by mRNA levels,
the expression patterns of p21WAF1/CIP1 were examined in cell
lines under upregulated PP2Cc conditions. Interestingly, the
level of p21WAF1/CIP1 mRNA was not signiﬁcantly changed
in PP2Cc-induced cells (Fig. 2B). These results indicate that
PP2Cc reduces the levels of p21WAF1/CIP1 protein but not
p21WAF1/CIP1 mRNA in 293 cells.
The functional relationship between PP2Cc and
p21WAF1/CIP1 prompted us to investigate whether the
phosphatase activity of PP2Cc might aﬀect the stability of
p21WAF1/CIP1. Using PP2Cc D496A, a phosphatase dead
mutant, the level of p21WAF1/CIP1 was investigated in cells.
As shown in Fig. 2C, p21WAF1/CIP1 in PP2Cc mutant cells
was resistant to degradation, whereas p21WAF1/CIP1 expression
was faint in wild-type PP2Cc-expressing cells, suggesting that
PP2Cc modiﬁes the fate of p21WAF1/CIP1 via phosphatase
activity.
3.3. Degradation of p21WAF1/CIP1 induced by PP2Cc
Since our results revealing the absence of p21WAF1/CIP1 in
PP2Cc-induced cells suggested dysregulation at the post-tran-
scriptional level, we tested the possibility of inhibiting the
increased degradation of p21WAF1/CIP1. To do this, we used a
speciﬁc proteasome inhibitor, MG132. Interestingly, treatment
with MG132 signiﬁcantly maintained an elevated level of
p21WAF1/CIP1 protein in PP2Cc-induced cells (Fig. 3). These
results suggest that downregulation of p21WAF1/CIP1 mediated
by PP2Cc occurred via the proteasome pathway. Thus,
PP2Cc may stimulate proteasome-related proteins for the
degradation of p21WAF1/CIP1.
3.4. Expression of p53 and Rb in cells expressing PP2Cc
Since the expression of p21WAF1/CIP1 could be regulated at
the transcriptional, post-transcriptional, or post-translational
level by p53-dependent and -independent mechanisms
[16,17], we investigated whether PP2Cc aﬀects p53 in 293 cells.
At 36 h after transfection, the expression of p53 was analyzed
by Western blotting. As shown in Fig. 4A, the level of p53 in
cells expressing PP2Cc was no diﬀerent compared with that in
cells expressing vector only. Furthermore, the expression of
p21WAF1/CIP1 in cells expressing exogenous p53 protein was
elevated regardless of PP2Cc. These results indicate that
Fig. 4. Expression of p53 and Rb in PP2Cc-expressing cells. (A) Cells
were transfected with PP2Cc and/or p53 plasmid. After 36 h, cells were
harvested and Western blotting was conducted with antibodies against
PP2Cc, p21, p53, and actin. (B) Cells expressing PP2Cc were isolated
and lysates were resolved using SDS–PAGE. Western blots were
probed with a-PP2Cc, a-Rb, a-p-Rb, a-cyclin E, and a-actin
antibodies.
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independent pathway. In addition, we investigated the expres-
sion of Rb protein under the same conditions. Interestingly,
the phosphorylation of Rb was decreased in PP2Cc-expressing
cells, though the expression of Rb protein was not signiﬁcantly
changed (Fig. 4B), suggesting that hypophosphorylation of Rb
is important in prolonging the S phase with PP2Cc-mediated
p21WAF1/CIP1 repression.4. Discussion
In this study, over-expression of PP2Cc decreased the G1 and
G2/M populations, whereas cells accumulated in the S phase.
Expression of PP2Cc reduced the levels of p21WAF1/CIP1
protein but not p21WAF1/CIP1 mRNA. The post-transcriptional
level of p21WAF1/CIP1 is known to be regulated by proteasome-
mediated degradation [16–19]. A proteasome blocker counter-
acted p21WAF1/CIP1 degradation in the S phase in our study.
Accelerated p21WAF1/CIP1 turnover in the S phase results from
upregulation of its normal degradation by the proteasome. One
possible explanation is that certain cell phases of the cell cycle
may be accelerated in cells expressing PP2Cc, and this could
promote proteasome-mediated degradation of the cell-cycle
machinery. The S phase stimulating factor skp2 is an attractive
candidate to directly regulate cell cycle progression and gener-
ate the signal of protein stability [20,21]. It is known that the
degradation of p21WAF1/CIP1 switches to a ubiquitin/Skp2-
dependent proteasome pathway [22,23]. In the case of the
SCFskp2 E3 ligase complex, phosphorylation of protein sub-
strates appears to play a major role in regulating the E3-sub-
strate interaction. Although phosphorylation is dispensable
for p21WAF1/CIP1 recognition and subsequent ubiquitination
by skp2 in vitro [22], the signal for p21WAF1/CIP1 recognition
by skp2 and subsequent ubiquitination has yet to be deﬁned.
In our study, proteasome inhibition led to accumulation of
p21WAF1/CIP1. This may be mono- or polyubiquitinated
p21WAF1/CIP1 intermediates. A direct interference study with
PP2Cc and skp2 using proteasome inhibitors is warranted as
a means of improving understanding of PP2Cc function in
mammalian cells. A systematic analysis is in progress to eluci-
date further the relationship between PP2Cc and p21WAF1/CIP1.
In conclusion, we showed with the example of p21WAF1/CIP1
that there is a proteasome pathway by which PP2Cc can reg-ulate protein stability. It remains to be determined which pro-
teins might be involved in the proteasome-dependent
degradation of p21WAF1/CIP1 in response to PP2Cc.
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